David A. Carter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David A. Carter has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Mark Allen
Florey Institute of Neuroscience and Mental Health Melbourne Vic Australia
6 shared publications - Stuart James McDougall
Florey Institute of Neuroscience and Mental Health Melbourne Vic Australia
4 shared publications Haoyao Guo
Florey Institute of Neuroscience and Mental Health, Victoria 3010, Australia
3 shared publications- Linda Alba Gallo
School of Biomedical Sciences, The University of Queensland
3 shared publications A. A. Connelly
Department of Physiology, The University of Melbourne , Victoria , Australia
2 shared publications- Clément Menuet
Inmed, INSERM, Aix-Marseille University, Marseille, France
2 shared publications
Latest Publications
- Open Access
- 29 May 2025
- Published by Elsevier in Autonomic Neuroscience
- Vol. 260, 103305
Hypothalamic excitatory input to AT1AR and TH expressing neurons of the nucleus of the solitary tract in mice
- 29 May 2025
- Published by Elsevier in Autonomic Neuroscience
- Vol. 260, 103305
Open AccessHypothalamic excitatory input to AT1AR and TH expressing neurons of the nucleus of the solitary tract in mice
- Open Access
Impaired spatial memory in adult vitamin D deficient BALB/c mice is associated with reductions in spine density, nitric oxide, and neural nitric oxide synthase in the hippocampus
Vitamin D deficiency is prevalent in adults and is associated with cognitive impairment. However, the mechanism by which adult vitamin D (AVD) deficiency affects cognitive function remains unclear. We examined spatial memory impairment in AVD-deficient BALB/c mice and its underlying mechanism by measuring spine density, long term potentiation (LTP), nitric oxide (NO), neuronal nitric oxide synthase (nNOS) and endothelial NOS (eNOS) in the hippocampus. Adult male BALB/c mice were fed a control or vitamin D deficient diet for 20 weeks. Spatial memory performance was measured using an active place avoidance (APA) task, where AVD-deficient mice had reduced latency entering the shock zone compared to controls. We characterised hippocampal spine morphology in the CA1 and dentate gyrus (DG) and made electrophysiological recordings in the hippocampus of behaviourally naïve mice to measure LTP. We next measured NO, as well as glutathione, lipid peroxidation and oxidation of protein products and quantified hippocampal immunoreactivity for nNOS and eNOS. Spine morphology analysis revealed a significant reduction in the number of mushroom spines in the CA1 dendrites but not in the DG. There was no effect of diet on LTP. However, hippocampal NO levels were depleted whereas other oxidation markers were unaltered by AVD deficiency. We also showed a reduced nNOS, but not eNOS, immunoreactivity. Finally, vitamin D supplementation for 10 weeks to AVD-deficient mice restored nNOS immunoreactivity to that seen in in control mice. Our results suggest that lower levels of NO, reduced nNOS immunostaining contribute to hippocampal-dependent spatial learning deficits in AVD-deficient mice.
Open AccessImpaired spatial memory in adult vitamin D deficient BALB/c mice is associated with reductions in spine density, nitric oxide, and neural nitric oxide synthase in the hippocampus
Vitamin D deficiency is prevalent in adults and is associated with cognitive impairment. However, the mechanism by which adult vitamin D (AVD) deficiency affects cognitive function remains unclear. We examined spatial memory impairment in AVD-deficient BALB/c mice and its underlying mechanism by measuring spine density, long term potentiation (LTP), nitric oxide (NO), neuronal nitric oxide synthase (nNOS) and endothelial NOS (eNOS) in the hippocampus. Adult male BALB/c mice were fed a control or vitamin D deficient diet for 20 weeks. Spatial memory performance was measured using an active place avoidance (APA) task, where AVD-deficient mice had reduced latency entering the shock zone compared to controls. We characterised hippocampal spine morphology in the CA1 and dentate gyrus (DG) and made electrophysiological recordings in the hippocampus of behaviourally naïve mice to measure LTP. We next measured NO, as well as glutathione, lipid peroxidation and oxidation of protein products and quantified hippocampal immunoreactivity for nNOS and eNOS. Spine morphology analysis revealed a significant reduction in the number of mushroom spines in the CA1 dendrites but not in the DG. There was no effect of diet on LTP. However, hippocampal NO levels were depleted whereas other oxidation markers were unaltered by AVD deficiency. We also showed a reduced nNOS, but not eNOS, immunoreactivity. Finally, vitamin D supplementation for 10 weeks to AVD-deficient mice restored nNOS immunoreactivity to that seen in in control mice. Our results suggest that lower levels of NO, reduced nNOS immunostaining contribute to hippocampal-dependent spatial learning deficits in AVD-deficient mice.
- Top Cited Papers
- 22 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6527) , 386-390
Convergent evolution of pain-inducing defensive venom components in spitting cobras
From offense to defense: Venom in snakes is largely used to subdue and/or kill prey, and most venoms have clear actions that facilitate death or paralysis. In one group of snakes, however, venom has evolved and shifted from predation to protection. Specifically, in three different lineages of “spitting” snakes, venom is used to deter predators. Kazandjian et al. show that similar adaptions have occurred within these lineages that transform cytotoxic components into a mixture that acts on mammalian sensory neurons and causes pain. The authors argue that increased predation on these lineages led to similar shifts in venom function. Science , this issue p. 386
- 22 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6527) , 386-390
Top Cited PapersConvergent evolution of pain-inducing defensive venom components in spitting cobras
From offense to defense: Venom in snakes is largely used to subdue and/or kill prey, and most venoms have clear actions that facilitate death or paralysis. In one group of snakes, however, venom has evolved and shifted from predation to protection. Specifically, in three different lineages of “spitting” snakes, venom is used to deter predators. Kazandjian et al. show that similar adaptions have occurred within these lineages that transform cytotoxic components into a mixture that acts on mammalian sensory neurons and causes pain. The authors argue that increased predation on these lineages led to similar shifts in venom function. Science , this issue p. 386
- Open Access
Sotagliflozin, a dual SGLT1/2 inhibitor, improves cardiac outcomes in a mouse model of early heart failure without diabetes
Aims: Selective SGLT2 inhibition reduces the risk of worsening heart failure and cardiovascular death in patients with existing heart failure, irrespective of diabetic status. We aimed to investigate the effects of dual SGLT1/2 inhibition, using sotagliflozin, on cardiac outcomes in non-diabetic and diabetic mice with cardiac pressure overload. Methods and Results: Five-week old male C57BL/6J mice were randomized to receive a high fat diet (HFD; 60% of calories from fat) to induce diabetes or remain on normal diet (ND) for 12 weeks. Transverse aortic constriction (TAC) was then employed to induce cardiac pressure-overload (50% increase in right:left carotid pressure versus sham surgery), resulting in features representative of heart failure with preserved ejection fraction. At five weeks into the dietary protocol, mice were treated for seven weeks by oral gavage once daily with sotagliflozin (10mg/kg body weight) or vehicle (0.1% tween 80). In ND non-diabetic mice, treatment with sotagliflozin attenuated cardiac hypertrophy and histological markers of cardiac fibrosis induced by TAC. These benefits were associated with profound diuresis and glucosuria, without shifts toward whole-body fatty acid utilisation nor increased cardiac ketolysis. In HFD diabetic mice, sotagliflozin did not attenuate cardiac injury induced by TAC. HFD mice had vacuolation of proximal tubular cells, associated with less profound diuresis and glucosuria, which may have compromised drug action and subsequent cardio-protection. Conclusion: We demonstrate the utility of dual SGLT1/2 inhibition in treating heart failure risk factors in the non-diabetic state. Its efficacy in high fat-induced diabetes with proximal tubular damage requires further study.
Open AccessSotagliflozin, a dual SGLT1/2 inhibitor, improves cardiac outcomes in a mouse model of early heart failure without diabetes
Aims: Selective SGLT2 inhibition reduces the risk of worsening heart failure and cardiovascular death in patients with existing heart failure, irrespective of diabetic status. We aimed to investigate the effects of dual SGLT1/2 inhibition, using sotagliflozin, on cardiac outcomes in non-diabetic and diabetic mice with cardiac pressure overload. Methods and Results: Five-week old male C57BL/6J mice were randomized to receive a high fat diet (HFD; 60% of calories from fat) to induce diabetes or remain on normal diet (ND) for 12 weeks. Transverse aortic constriction (TAC) was then employed to induce cardiac pressure-overload (50% increase in right:left carotid pressure versus sham surgery), resulting in features representative of heart failure with preserved ejection fraction. At five weeks into the dietary protocol, mice were treated for seven weeks by oral gavage once daily with sotagliflozin (10mg/kg body weight) or vehicle (0.1% tween 80). In ND non-diabetic mice, treatment with sotagliflozin attenuated cardiac hypertrophy and histological markers of cardiac fibrosis induced by TAC. These benefits were associated with profound diuresis and glucosuria, without shifts toward whole-body fatty acid utilisation nor increased cardiac ketolysis. In HFD diabetic mice, sotagliflozin did not attenuate cardiac injury induced by TAC. HFD mice had vacuolation of proximal tubular cells, associated with less profound diuresis and glucosuria, which may have compromised drug action and subsequent cardio-protection. Conclusion: We demonstrate the utility of dual SGLT1/2 inhibition in treating heart failure risk factors in the non-diabetic state. Its efficacy in high fat-induced diabetes with proximal tubular damage requires further study.
- 16 March 2020
- Published by Wiley in Nephrology
- Vol. 25 (7) , 575-581
Validation of non‐invasive transcutaneous measurement for glomerular filtration rate in lean and obese C57BL/6J mice
Aim: The measurement of glomerular filtration rate (GFR) in experimental rodents is pivotal to understanding the progression of kidney disease and benefits of treatment strategies. A non‐invasive clearance device has been developed, which measures transcutaneous decay of injected FITC‐sinistrin in conscious rodents. The technique was validated against the well‐established plasma clearance method in the same mice, but on consecutive days, using only models of uninephrectomy and polycystic kidney disease. We aimed to validate this widely used technique in the same lean or obese mice, at the same time.Methods: Five‐week‐old male C57BL/6J mice were randomised to a high fat diet (n = 12) or normal diet (n = 11) for 10 weeks. Transcutaneous and plasma clearance of FITC‐sinistrin were measured simultaneously in each mouse.Results: In lean mice, there was a positive correlation between transcutaneous and plasma derived GFR (P < .01, R2 = .704), although there was an approximate 40% underestimation by the transcutaneous method (P < .0001). In obese mice, no correlation was observed between transcutaneous and plasma derived GFR, nor elimination half‐life which removes any effect of the conversion factor and injected dose. The limits of agreement in a Bland‐Altman plot were narrower when we used new conversion factors derived from mice in the current study and, in lean mice, a generic conversion factor which assumes 20% extracellular volume.Conclusion: The non‐invasive clearance device may be useful for serial GFR measurements in lean and healthy mice, provided validation studies have been carried out, but its utility in obesity requires further study.
- 16 March 2020
- Published by Wiley in Nephrology
- Vol. 25 (7) , 575-581
Validation of non‐invasive transcutaneous measurement for glomerular filtration rate in lean and obese C57BL/6J mice
Aim: The measurement of glomerular filtration rate (GFR) in experimental rodents is pivotal to understanding the progression of kidney disease and benefits of treatment strategies. A non‐invasive clearance device has been developed, which measures transcutaneous decay of injected FITC‐sinistrin in conscious rodents. The technique was validated against the well‐established plasma clearance method in the same mice, but on consecutive days, using only models of uninephrectomy and polycystic kidney disease. We aimed to validate this widely used technique in the same lean or obese mice, at the same time.Methods: Five‐week‐old male C57BL/6J mice were randomised to a high fat diet (n = 12) or normal diet (n = 11) for 10 weeks. Transcutaneous and plasma clearance of FITC‐sinistrin were measured simultaneously in each mouse.Results: In lean mice, there was a positive correlation between transcutaneous and plasma derived GFR (P < .01, R2 = .704), although there was an approximate 40% underestimation by the transcutaneous method (P < .0001). In obese mice, no correlation was observed between transcutaneous and plasma derived GFR, nor elimination half‐life which removes any effect of the conversion factor and injected dose. The limits of agreement in a Bland‐Altman plot were narrower when we used new conversion factors derived from mice in the current study and, in lean mice, a generic conversion factor which assumes 20% extracellular volume.Conclusion: The non‐invasive clearance device may be useful for serial GFR measurements in lean and healthy mice, provided validation studies have been carried out, but its utility in obesity requires further study.
- 1 January 2020
- Published by Elsevier in The Journal of Pain
- Vol. 21 (1-2) , 182-194
Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice
- 1 January 2020
- Published by Elsevier in The Journal of Pain
- Vol. 21 (1-2) , 182-194
Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice
- 1 June 2018
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 314 (6) , R858-R869
Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice
There is an increased incidence of heart failure in individuals with diabetes mellitus (DM). The co-existence of kidney disease in DM exacerbates the cardiovascular prognosis. Researchers have attempted to combine the critical features of heart failure, using transverse aortic constriction, with DM in mice but variable findings have been reported. Furthermore, kidney outcomes have not been assessed in this setting thus its utility as a model of heart failure in DM and kidney disease is unknown. We generated a mouse model of obesity, hyperglycemia and mild kidney pathology by feeding male C57BL/6J mice a high fat diet (HFD). Cardiac pressure overload was surgically induced using transverse aortic constriction (TAC). Normal diet (ND) and sham controls were included. Heart failure risk factors were evident at 8 weeks post-TAC, including increased left ventricular mass (+49% in ND and +35% in HFD), cardiomyocyte hypertrophy (+40% in ND and +28% in HFD), and interstitial and perivascular fibrosis (Masson's Trichrome and Picrosirius red positivity). High fat feeding did not exacerbate the TAC-induced cardiac outcomes. At 11 weeks post-TAC in a separate mouse cohort, echocardiography revealed reduced left ventricular size and increased left ventricular wall thickness; the latter evident in ND mice only. Systolic function was preserved in the TAC mice, and similar between ND and HFD. Thus, combined high fat feeding and TAC in mice did not model the increased incidence of heart failure in DM patients. This model, however, may mimic the better cardiovascular prognosis seen in overweight and obese heart failure patients.
- 1 June 2018
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 314 (6) , R858-R869
Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice
There is an increased incidence of heart failure in individuals with diabetes mellitus (DM). The co-existence of kidney disease in DM exacerbates the cardiovascular prognosis. Researchers have attempted to combine the critical features of heart failure, using transverse aortic constriction, with DM in mice but variable findings have been reported. Furthermore, kidney outcomes have not been assessed in this setting thus its utility as a model of heart failure in DM and kidney disease is unknown. We generated a mouse model of obesity, hyperglycemia and mild kidney pathology by feeding male C57BL/6J mice a high fat diet (HFD). Cardiac pressure overload was surgically induced using transverse aortic constriction (TAC). Normal diet (ND) and sham controls were included. Heart failure risk factors were evident at 8 weeks post-TAC, including increased left ventricular mass (+49% in ND and +35% in HFD), cardiomyocyte hypertrophy (+40% in ND and +28% in HFD), and interstitial and perivascular fibrosis (Masson's Trichrome and Picrosirius red positivity). High fat feeding did not exacerbate the TAC-induced cardiac outcomes. At 11 weeks post-TAC in a separate mouse cohort, echocardiography revealed reduced left ventricular size and increased left ventricular wall thickness; the latter evident in ND mice only. Systolic function was preserved in the TAC mice, and similar between ND and HFD. Thus, combined high fat feeding and TAC in mice did not model the increased incidence of heart failure in DM patients. This model, however, may mimic the better cardiovascular prognosis seen in overweight and obese heart failure patients.
- Open Access
- 1 February 2018
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 314 (2) , R282-R293
Viscerosensory input drives angiotensin II type 1A receptor-expressing neurons in the solitary tract nucleus
Homeostatic regulation of visceral organ function requires integrated processing of neural and neurohormonal sensory signals. The nucleus of the solitary tract (NTS) is the primary sensory nucleus for cranial visceral sensory afferents. Angiotensin II (ANG II) is known to modulate peripheral visceral reflexes, in part, by activating ANG II type 1A receptors (AT1AR) in the NTS. AT1AR-expressing NTS neurons occur throughout the NTS with a defined subnuclear distribution, and most of these neurons are depolarized by ANG II. In this study we determined whether AT1AR-expressing NTS neurons receive direct visceral sensory input, and whether this input is modulated by ANG II. Using AT1AR-GFP mice to make targeted whole cell recordings from AT1AR-expressing NTS neurons, we demonstrate that two-thirds (37 of 56) of AT1AR-expressing neurons receive direct excitatory, visceral sensory input. In half of the neurons tested (4 of 8) the excitatory visceral sensory input was significantly reduced by application of the transient receptor potential vallinoid type 1 receptor agonist, capsaicin, indicating AT1AR-expressing neurons can receive either C- or A-fiber-mediated input. Application of ANG II to a subset of second-order AT1AR-expressing neurons did not affect spontaneous, evoked, or asynchronous glutamate release from visceral sensory afferents. Thus it is unlikely that AT1AR-expressing viscerosensory neurons terminate on AT1AR-expressing NTS neurons. Our data suggest that ANG II is likely to modulate multiple visceral sensory modalities by altering the excitability of second-order AT1AR-expressing NTS neurons.
- 1 February 2018
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 314 (2) , R282-R293
Open AccessViscerosensory input drives angiotensin II type 1A receptor-expressing neurons in the solitary tract nucleus
Homeostatic regulation of visceral organ function requires integrated processing of neural and neurohormonal sensory signals. The nucleus of the solitary tract (NTS) is the primary sensory nucleus for cranial visceral sensory afferents. Angiotensin II (ANG II) is known to modulate peripheral visceral reflexes, in part, by activating ANG II type 1A receptors (AT1AR) in the NTS. AT1AR-expressing NTS neurons occur throughout the NTS with a defined subnuclear distribution, and most of these neurons are depolarized by ANG II. In this study we determined whether AT1AR-expressing NTS neurons receive direct visceral sensory input, and whether this input is modulated by ANG II. Using AT1AR-GFP mice to make targeted whole cell recordings from AT1AR-expressing NTS neurons, we demonstrate that two-thirds (37 of 56) of AT1AR-expressing neurons receive direct excitatory, visceral sensory input. In half of the neurons tested (4 of 8) the excitatory visceral sensory input was significantly reduced by application of the transient receptor potential vallinoid type 1 receptor agonist, capsaicin, indicating AT1AR-expressing neurons can receive either C- or A-fiber-mediated input. Application of ANG II to a subset of second-order AT1AR-expressing neurons did not affect spontaneous, evoked, or asynchronous glutamate release from visceral sensory afferents. Thus it is unlikely that AT1AR-expressing viscerosensory neurons terminate on AT1AR-expressing NTS neurons. Our data suggest that ANG II is likely to modulate multiple visceral sensory modalities by altering the excitability of second-order AT1AR-expressing NTS neurons.
- 1 October 2017
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 313 (4) , R438-R449
Functional and neurochemical characterization of angiotensin type 1A receptor-expressing neurons in the nucleus of the solitary tract of the mouse
Angiotensin II acts via two main receptors within the central nervous system, with the type 1A receptor (AT1AR) most widely expressed in adult neurons. Activation of the AT1R in the nucleus of the solitary tract (NTS), the principal nucleus receiving central synapses of viscerosensory afferents, modulates cardiovascular reflexes. Expression of the AT1R occurs in high density within the NTS of most mammals, including humans, but the fundamental electrophysiological and neurochemical characteristics of the AT1AR-expressing NTS neurons are not known. To address this, we have used a transgenic mouse, in which the AT1AR promoter drives expression of green fluorescent protein (GFP). Approximately one-third of AT1AR-expressing neurons express the catecholamine-synthetic enzyme tyrosine hydroxylase (TH), and a subpopulation of these stained for the transcription factor paired-like homeobox 2b (Phox2b). A third group, comprising approximately two-thirds of the AT1AR-expressing NTS neurons, showed Phox2b immunoreactivity alone. A fourth group in the ventral subnucleus expressed neither TH nor Phox2b. In whole cell recordings from slices in vitro, AT1AR-GFP neurons exhibited voltage-activated potassium currents, including the transient outward current and the M-type potassium current. In two different mouse strains, both AT1AR-GFP neurons and TH-GFP neurons showed similar AT1AR-mediated depolarizing responses to superfusion with angiotensin II. These data provide a comprehensive description of AT1AR-expressing neurons in the NTS and increase our understanding of the complex actions of this neuropeptide in the modulation of viscerosensory processing.
- 1 October 2017
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 313 (4) , R438-R449
Functional and neurochemical characterization of angiotensin type 1A receptor-expressing neurons in the nucleus of the solitary tract of the mouse
Angiotensin II acts via two main receptors within the central nervous system, with the type 1A receptor (AT1AR) most widely expressed in adult neurons. Activation of the AT1R in the nucleus of the solitary tract (NTS), the principal nucleus receiving central synapses of viscerosensory afferents, modulates cardiovascular reflexes. Expression of the AT1R occurs in high density within the NTS of most mammals, including humans, but the fundamental electrophysiological and neurochemical characteristics of the AT1AR-expressing NTS neurons are not known. To address this, we have used a transgenic mouse, in which the AT1AR promoter drives expression of green fluorescent protein (GFP). Approximately one-third of AT1AR-expressing neurons express the catecholamine-synthetic enzyme tyrosine hydroxylase (TH), and a subpopulation of these stained for the transcription factor paired-like homeobox 2b (Phox2b). A third group, comprising approximately two-thirds of the AT1AR-expressing NTS neurons, showed Phox2b immunoreactivity alone. A fourth group in the ventral subnucleus expressed neither TH nor Phox2b. In whole cell recordings from slices in vitro, AT1AR-GFP neurons exhibited voltage-activated potassium currents, including the transient outward current and the M-type potassium current. In two different mouse strains, both AT1AR-GFP neurons and TH-GFP neurons showed similar AT1AR-mediated depolarizing responses to superfusion with angiotensin II. These data provide a comprehensive description of AT1AR-expressing neurons in the NTS and increase our understanding of the complex actions of this neuropeptide in the modulation of viscerosensory processing.
- Open Access
- 1 April 2016
- Published by Wiley in The FASEB Journal
- Vol. 30 (S1)
Angiotensin type 1A receptor expressing neurons in the NTS receive direct solitary tract excitatory neurotransmission
Second order neurons in the nucleus of the solitary tract (NTS) receive direct viscero‐sensory afferents from internal organs via the solitary tract (ST) to coordinate autonomic reflexes. Approximately 90% ST vagal afferents from the heart and lungs are unmyelinated c‐fibres and express transient receptor potential vallinoid type 1 (TRPV1). Activation of the angiotensin type 1A receptor (AT1AR) in the NTS modulates cardiorespiratory reflexes and is thought to potentiate ST excitatory input. Here we aimed to characterise ST input to AT1AR expressing NTS neurons, and determine what proportion of the monosynaptic afferents express TPRV1. Second, we determined the impact of angiotensin II (AngII) on ST neurotransmission to AT1AR expressing NTS neurons. We employed in vitro slice electrophysiology and whole cell recordings. Twenty‐two transgenic mice expressing green fluorescent protein in AT1AR neurons were sacrificed and 250 μm horizontal brain stem slices were prepared and superfused with artificial cerebrospinal fluid. Electrical stimulation of the ST evoked low jitter excitatory post‐synaptic currents (ST‐EPSCs) in 28 of 41 GFP positive neurons, identifying them as second order. The normalised amplitude (eEPSC/eEPSC MAX ) and paired pulse ration (PPR) of ST‐EPSCs (50 Hz, 200 μs) and frequency of spontaneous (F‐sEPSCs) and asynchronous EPSCs (F‐aEPSCs) were analysed before and during the addition of 100 nM capsaicin (CAP) or 2 μM AngII to the superfusate. CAP decreased F‐aEPSCs (CSF: 13.9 ± 2.3 Hz, CAP: 0.3 ± 2.7 Hz, n = 5), however only inhibited ST‐EPSCs in 1/5 second order neurons tested. AngII had no effect on ST‐EPSC amplitude (CSF: 0.84 ± 0.03, AngII: 0.85 ± 0.05), PPR (CSF: 0.34 ± 0.05, AngII: 0.34 ± 0.04, n = 8) or F‐sEPSC. Combined, this data indicates that NTS AT1AR neurons receive direct viscerosensory signals mostly via TRPV1‐ve pathways. Further, that AT1AR is not likely to be expressed on the excitatory ST axons/terminals contacting these AT1AR expressing NTS neurons. This suggests AT1AR neurons in the NTS receive predominately Aδ‐fibre input which relay high fidelity, low threshold signals from the viscera through the central nervous system. Support or Funding Information This work is supported by a National heart foundation post‐graduate research scholarship.
- 1 April 2016
- Published by Wiley in The FASEB Journal
- Vol. 30 (S1)
Open AccessAngiotensin type 1A receptor expressing neurons in the NTS receive direct solitary tract excitatory neurotransmission
Second order neurons in the nucleus of the solitary tract (NTS) receive direct viscero‐sensory afferents from internal organs via the solitary tract (ST) to coordinate autonomic reflexes. Approximately 90% ST vagal afferents from the heart and lungs are unmyelinated c‐fibres and express transient receptor potential vallinoid type 1 (TRPV1). Activation of the angiotensin type 1A receptor (AT1AR) in the NTS modulates cardiorespiratory reflexes and is thought to potentiate ST excitatory input. Here we aimed to characterise ST input to AT1AR expressing NTS neurons, and determine what proportion of the monosynaptic afferents express TPRV1. Second, we determined the impact of angiotensin II (AngII) on ST neurotransmission to AT1AR expressing NTS neurons. We employed in vitro slice electrophysiology and whole cell recordings. Twenty‐two transgenic mice expressing green fluorescent protein in AT1AR neurons were sacrificed and 250 μm horizontal brain stem slices were prepared and superfused with artificial cerebrospinal fluid. Electrical stimulation of the ST evoked low jitter excitatory post‐synaptic currents (ST‐EPSCs) in 28 of 41 GFP positive neurons, identifying them as second order. The normalised amplitude (eEPSC/eEPSC MAX ) and paired pulse ration (PPR) of ST‐EPSCs (50 Hz, 200 μs) and frequency of spontaneous (F‐sEPSCs) and asynchronous EPSCs (F‐aEPSCs) were analysed before and during the addition of 100 nM capsaicin (CAP) or 2 μM AngII to the superfusate. CAP decreased F‐aEPSCs (CSF: 13.9 ± 2.3 Hz, CAP: 0.3 ± 2.7 Hz, n = 5), however only inhibited ST‐EPSCs in 1/5 second order neurons tested. AngII had no effect on ST‐EPSC amplitude (CSF: 0.84 ± 0.03, AngII: 0.85 ± 0.05), PPR (CSF: 0.34 ± 0.05, AngII: 0.34 ± 0.04, n = 8) or F‐sEPSC. Combined, this data indicates that NTS AT1AR neurons receive direct viscerosensory signals mostly via TRPV1‐ve pathways. Further, that AT1AR is not likely to be expressed on the excitatory ST axons/terminals contacting these AT1AR expressing NTS neurons. This suggests AT1AR neurons in the NTS receive predominately Aδ‐fibre input which relay high fidelity, low threshold signals from the viscera through the central nervous system. Support or Funding Information This work is supported by a National heart foundation post‐graduate research scholarship.